| INTRODUCTION
Seasonal influenza infection can be a burden on public health authorities. Rapid diagnosis is an important initial step in the appropriate management of influenza disease. Traditionally, viral cultures, serological tests, rapid antigen tests, and molecular methods have been used to diagnose influenza infection. 1 Rapid influenza diagnostic tests (RIDTs) have been used widely in the clinical setting because they can be handled readily and at relatively low cost, although they have low and variable detection sensitivities. Thus, a negative RIDT result does not confirm a status free of influenza virus infection. The clinical sensitivities of these tests have been reported to range from 20% to 90%, according to sample collection method, storage and transport, specimen type, swab and transport media used, and degree of adherence to manufacturers' recommendations for test procedures. 1 The performance of RIDTs is also dependent on the prevalence of the influenza viruses circulating in the population. 2, 3 Furthermore, clinicians should be cautious about using RIDTs in certain patient populations and with respect to how the results should be interpreted. [3] [4] [5] Thus, further validation of RIDTs should be provided before routine clinical use. In this study, we compared three RIDTs with digital readout systems, and one conventional RIDT, with respect to the detection sensitivity and relative limit of detection according to influenza subtype.
| MATERIALS AND METHODS
We included 218 left-over nasopharyngeal swab specimens from nonduplicated patients who visited the hospital with suspicion of influenza infection. A total of 218 specimens were sum of 90 adults and 128 children (0-17 years old). All specimens were deeply frozen at −70°C or lower before the comparison tests. Nasopharyngeal swab specimens were collected from patients, between neonates and 90 years old, from 
| Conventional rapid influenza antigen detection test
The SD Bioline Influenza Ag A/B/A(H1N1/2009) (Standard Diagnostics)
is an immunochromatographic assay for the qualitative detection of influenza virus types A and type B using embedded mouse monoclonal anti-influenza A and anti-influenza B antibodies on the test strip. 7 Briefly, 75 μL of nasopharyngeal specimen in UTM was mixed with the same volume of reagent solution. The test strip was inserted into a tube containing the total volume of 150 μL of the reaction mixture. Test results were examined visually and interpreted after 10-15 minutes.
| Real-time reverse transcription PCR (rRT-PCR) analysis
Viral RNAs were extracted from 530 μL of the nasopharyngeal specimen using the SeePrep12 Viral NA kit (Seegene) and the SeePrep12
Viral NA instrument (Seegene). This is an automated nucleic acid (NA) extraction system for downstream detection, for extracting and purifying NAs using a magnetic bead method. An internal control (10 μL)
was added to each specimen before the extraction step to confirm the entire process, from NA extraction to PCR.
The Anyplex FluA/B Typing Real-time Detection (Seegene) 8 
| Comparison of influenza subtype detection limits
A comparison study was performed to compare the influenza subtype detection capacity among four different RIDT assays using 20 different influenza antigen reagents from the National Institute for Biological Standards and Control (NIBSC). First, the stock solution of each subtype reagent was diluted in the recommended buffer to 512 ng/mL. Then, the 512 ng/mL NIBCS influenza A subtypes were diluted serially to 128, 64, 16, 8, 4, 2, and 1 ng/mL. The 512 ng/mL NIBCS influenza B subtypes were diluted serially to 128, 64, 16, and 8 ng/mL. The diluted subtype reagents were measured to determine and compare the detection limit of each RIDT.
| Cross-reactivity with other respiratory viruses
The NL63, 1 HRV+HBoV were tested for cross-reactivity of four RIDTs.
| RESULTS

| Comparison of RIDT specification
The four RIDTs were compared according to sample volume, assay time, discrimination of influenza A and B, recommended specimen types, and test principles. We briefly describe the specifications of each RIDT in Table 1 . Also, the 218 enrolled samples were classified as 73 cases of influenza A, 60 of influenza B, and 85 negatives ( Table 2 ).
| Comparison of sensitivity and specificity
For influenza A, BUDDI, Sofia, Veritor, and Bioline showed 87.7%, 94.5%, 87.7%, and 72.6% detection sensitivity and 100%, 97.7%, 96.5%, and 100% detection specificity, respectively. 
T A B L E 1 Characteristics of each rapid diagnostic test for influenza virus detection
Rapid test kits
| Comparison of sensitivity and specificity according to age
In children (birth to 17), for influenza A, BUDDI, Sofia, Veritor, and 
| Comparison of RIDT detection limits
Serially diluted NIBSC solutions showed some differences in low-level detection power between the RIDTs. Overall, the digitalized influenza detection tests had a higher detection power than those of the con- (Table 5 ).
| Cross-reactivity for other respiratory viruses
We identified that four RIDTs did not show cross-reactivity results in 29 specimens which had other respiratory viruses excluding influenza viruses.
| DISCUSSION
Influenza can be a major public health burden. Both influenza A and influenza B have caused over 200 000 hospitalizations and 30 000-50 000 deaths.
13-17 Diagnosis of influenza infections include viral
isolation in cell culture, immunofluorescence assays, nucleic acid amplification tests, immunochromatography-based rapid diagnostic tests, etc.
18
The rapid diagnosis of influenza may help in managing patients and lowering overall treatment costs. The available rapid diagnostic assays are relatively simple to perform and can produce results within less than 30 minutes, but they suffer from inaccuracy, with widely varying diagnostic sensitivities and specificities. 3, 19 Indeed, RIDTs may have inconsistent accuracy, with reported sensitivities ranging from 10% to 80%, 3, 5, 20, 21 whereas specificity usually exceeds 90%.
In this study, we evaluated a new RIDT, BUDDI, for the first time.
BUDDI is underpinned by an immunochromatographic method with a digital readout system. The reaction band of BUDDI is digitalized according to reaction intensity. Final results of BUDDI can be transferred through a network to another place to help rapid diagnosis. The sensitivities were higher in the digital readout systems than in the "conventional" RIDT, as we expected. Sofia showed the highest sensitivity for influenza A and B detection. BUDDI showed the same sensitivity as Veritor. The cause of the difference may be related to the immunofluorescence technology of Sofia, which enhances its sensitivity. In this study, we identified 66 influenza H1N1 subtype among 73 influenza
T A B L E 3 Performance characteristics of four rapid influenza diagnostic tests for the detection of influenza A/B compared to RT-PCR
Influenza type
Rapid test Sensitivity % (n, 95% CI) Specificity % (n, 95% CI) PPV % (n, 95% CI) NPV % (n, 95% CI) T A type persons (90.4%) through real-time PCR. It is important to understand the detection power of RIDT according to the influenza subtypes. Because influenza shows seasonal variations, specific influenza subtypes should be considered in upgrade of RIDTS.
We also compared the four RIDTs according to the NIBSC sub- These differences could be caused by different coverage levels of monoclonal antibodies to specific influenza subtypes. RIDTs should be updated to target prevalent influenza subtypes and to identify many influenza subtypes (to increase detection sensitivity).
This study had some limitations. First, we did not include large number of samples and various influenza subtypes. Second, the mean age of the enrolled individuals was relatively young, at 10-32.2 years, for a random selection within a specific period. Cruz et al. In conclusion, RIDTs with digital readout systems showed higher detection sensitivity than a conventional rapid test. The fluorescence technique of Sofia gave it the highest detection sensitivity, but there were differences in low-level detection power according to influenza subtype. Further well-designed prospective studies are needed for additional assessment of the value of updated RIDTs according to specific influenza subtypes.
